EP PerMed CARMEN2026 (Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases)

The EP PerMed CARMEN2026 call is a multilateral research funding opportunity under the European Partnership for Personalised Medicine supporting projects on personalised medicine for cardiovascular, metabolic and kidney diseases. Projects must involve consortia of three to six partners from at least three participating partner countries and have a maximum duration of 36 months. The call awards project funding (maximum €450,000 per FWF project leader) and is co-financed by national/regional funders and the European Union.

Project funding up to €450,000 per FWF project leader for projects of up to 36 months; funding administered by national/regional funders and co-financed by the EU.

Researchers at universities, non-university research institutions and relevant industrial research departments active in personalised medicine; projects must be carried by 3–6 partners from at least three participating partner countries and researchers are funded by their respective national/regional funding organisations.

Two-stage submission: submit concept proposals to the central Call Secretariat electronic submission system by the concept deadline; invited full proposals submitted by the full proposal deadline. Additionally, administrative and financial data and scientific abstracts must be submitted to FWF's elane system in the specified program categories and by their local-deadlines.